Delivery Order SPE2DB20D3103-SPE2DB25FP5S6
- Not listed
- The Defense Logistics Agency awarded a $11,187.56 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Calquence 100 mg tablets (60-count units). The contract is firm fixed price with no set-aside designation and is scheduled for completion by September 30, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $5,593.77. This competitively awarded, firm fixed-price delivery order is non-set-aside and scheduled for completion by September 12, 2025. The award leverages AmerisourceBergen's position as a prime contractor under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), a $999.999 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Calquence 100 mg tablets (60-unit quantity) with a ceiling value of $5,593.77. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The ultimate completion date is October 6, 2025, with performance occurring at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Calquence 100 mg tablets (60-count package) valued at $11,187.56. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement under the company's existing indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 11, 2025, for the supply of Calquence 100 mg tablets (60-count units) valued at $5,593.77, with completion expected by April 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Calquence 100 mg tablets (60 count) with a ceiling value of $5,593.77. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order is scheduled for completion by...
- The Defense Logistics Agency awarded a $11,187.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Calquence 100 mg tablets (60-count units). The contract, which is non-set-aside and competitively awarded, is scheduled for completion by August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $11,187.56. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The award carries no set-aside designation and was...
- The Defense Logistics Agency awarded a $5,593.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Calquence 100 mg tablets (60-count units). The contract, which is expected to be completed by August 11, 2025, is non-set-aside and represents a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Calquence 100 mg tablets (60-count units) valued at $5,593.77 with a firm fixed price structure. The contract, issued without set-aside designation, demonstrates competitive award practices and carries an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP5S6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Calquence 100 mg tablets (60-count units) valued at $11,187.56. This firm fixed-price delivery order, which is expected to be completed by August 8, 2025, represents a non-competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company holds a significant $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical running through December 2026, which serves as a global pharmaceutical support vehicle enabling the delivery of a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Calquence, an oncology medication, exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare systems through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 7/18/25 |